12:33 PM EST - Oncolytics Biotech Inc. : Announced financial results and operational highlights for the quarter ended June 30, 2018. At June 30, 2018, the company reported $18.7 million in cash and cash equivalents. Net loss was $4.2 million, compared to $4.3 million in the prior-year. Oncolytics Biotech Inc.
shares T.ONC are trading down $0.55 at $5.70.
